92146-66-2

Usage

Uses

Used in Pharmaceutical Synthesis:
1-(3-methylbenzyl)cyclopropanamine(SALTDATA: HCl) is utilized as a key precursor in the production of various pharmaceuticals and organic compounds. Its unique chemical structure allows for the creation of a diverse range of molecules with potential therapeutic applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(3-methylbenzyl)cyclopropanamine(SALTDATA: HCl) is employed for its potential to contribute to the development of novel drugs. Its chemical properties make it a valuable building block for designing and synthesizing new molecules with specific biological activities.
Used in Central Nervous System Research:
1-(3-methylbenzyl)cyclopropanamine(SALTDATA: HCl) may have biological activities and effects on the central nervous system. As such, it is used in research aimed at understanding its pharmacological properties and potential applications in treating neurological disorders or conditions. Further research is required to fully comprehend its impact on the central nervous system and its therapeutic potential.

Upstream product

• 29765-57-9 1-(3-Methyl-benzyl)-cyclopropanecarbonyl chloride 
• 29805-83-2 1-(3-Methyl-benzyl)-cyclopropanecarboxylic acid ethyl ester 
• 29765-43-3 1-(3-Methyl-benzyl)-cyclopropanecarboxylic acid 

Relevant academic research and scientific papers

Substituted cycloalkyl derivatives for the treatment of respiratory diseases

N-(Phenyl-substituted cycloalkyl or cycloalkylmethyl)-phenylethanolamine derivatives (I) (including benzo-heterocyclic analogs) are new. Also new are cyclopropylamine or cyclopropylmethylamine derivative intermediates (II). Phenylethanolamine derivatives of formula (I) (including optical isomers, enantiomer mixtures and racemates) and their salts, solvates and hydrates are new. n : 0 or 1; m : 1-4; X : direct bond, 2-6C alkenylene, -O-Q-, -NH-Q-, -S-Q- or -Q-; Q : 1-6C alkylene; R 1>H; and R 3>hydroxyalkyl or halo; or R 1> + R 2>OCH 2CONH, CH 2CH 2CONH, CH=CHCONH, NHCH 2CONH, SCH 2CONH, OCONH, SCONH, NHCONH or OCH 2SO 2NH (all optionally substituted (os) by 1 or 2 of alkyl, OH or halo); R 3>, R 4>H, OH, halo, 1-6C alkyl, 1-6C haloalkyl, 1-6C hydroxyalkyl, NH 2 or mono- or dialkylamino; R 5> - R 8>H, OR 9>, halo, 1-6C alkyl, 1-6C haloalkyl, 1-6C hydroxyalkyl, 3-6C cycloalkyl, 3-6C hydroxycycloalkyl, CN, NO 2, COR 9>, COOR 9>, CONR 10>R 11>, NR 10>R 11>, NR 10>COR 9>, NR 10>SO 2R 12>, SR 12>, SOR 12>, SO 2R 12>, SO 2NR 10>R 11> or halo; or two vicinal groups R 6> - R 8> together= 2-6C alkylene, 2-6C alkenylene or O-Q-O (all os by 1 or 2 of alkyl, alkoxy, OH or halo); R 9> - R 11>H, alkyl, aryl or arylalkyl; R 12>alkyl, aryl or arylalkyl; unless specified otherwise alkyl moieties have 1-4C and aryl moieties 6-10C. An independent claim is included for cycloalkylamine or cycloalkylalkylamine derivative intermediates of formula (II) as new compounds, provided that m= 1. [Image] [Image] ACTIVITY : Antiinflammatory; antiasthmatic; antiallergic; virucide; antibacterial; fungicide; protozoacide; anthelmintic; cardiant; dermatological; immunosuppressive; tocolytic; antiarrhythmic; vasotropic; antipruritic. MECHANISM OF ACTION : beta -Mimetic.